Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan; Department of Applied Pharmacy and Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
J Control Release. 2022 Dec;352:961-969. doi: 10.1016/j.jconrel.2022.11.014. Epub 2022 Nov 16.
In this review, we describe the current status and challenges in applying machine-learning techniques to the analysis and prediction of pharmacokinetic data. The theory of pharmacokinetics has been developed over decades on the basis of physiology and reaction kinetics. Mathematical models allow the reduction of pharmacokinetic data to parameter values, giving insight and understanding into ADME processes and predicting the outcome of different dosing scenarios. However, much information hidden in the data is lost through conceptual simplification with models. It is difficult to use mechanistic models alone to predict diverse pharmacokinetic time profiles, including inter-drug and inter-individual differences, in a cross-sectional manner. Machine learning is a prediction platform that can handle complex phenomena through data-driven analysis. As a resule, machine learning has been successfully adopted in various fields, including image recognition and language processing, and has been used for over two decades in pharmacokinetic research, primarily in the area of quantitative structure-activity relationships for pharmacokinetic parameters. Machine-learning models are generally known to provide better predictive performance than conventional linear models. Owing to the recent success in deep learning, models with new structures are being consistently proposed. These models include transfer learning and generative adversarial networks, which contribute to the effective use of a limited amount of data by diverting existing similar models or generating pseudo-data. How to make such newly emerging machine learning technologies applicable to meet challenges in the pharmacokinetics/pharmacodynamics field is now the key issue.
在这篇综述中,我们描述了将机器学习技术应用于分析和预测药代动力学数据的现状和挑战。药代动力学理论是基于生理学和反应动力学发展起来的,已经有几十年的历史了。数学模型允许将药代动力学数据简化为参数值,从而深入了解 ADME 过程并预测不同给药方案的结果。然而,通过模型的概念简化,数据中隐藏了很多信息。仅使用机械模型很难以横向的方式预测不同的药代动力学时间曲线,包括药物间和个体间的差异。机器学习是一种通过数据驱动分析处理复杂现象的预测平台。因此,机器学习已经在各种领域成功应用,包括图像识别和语言处理,并在药代动力学研究中使用了二十多年,主要用于药代动力学参数的定量构效关系领域。机器学习模型通常被认为提供了比传统线性模型更好的预测性能。由于深度学习的近期成功,新结构的模型不断被提出。这些模型包括迁移学习和生成对抗网络,它们通过转移现有的相似模型或生成伪数据来帮助有效利用有限的数据量。如何使这些新出现的机器学习技术能够应用于满足药代动力学/药效学领域的挑战,现在是关键问题。